Alliance For Clinical Trials In Oncology
Clinical trials sponsored by Alliance For Clinical Trials In Oncology, explained in plain language.
-
New hope for seniors with breast cancer: safer combo therapy shows promise
Disease control CompletedThis study looked at how well older adults (70+) with advanced, hormone-positive breast cancer tolerate a combination of palbociclib plus either letrozole or fulvestrant. The goal was to understand side effects and find factors that might predict who handles treatment better. 93 …
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 08:01 UTC
-
New combo targets Hard-to-Treat colon cancer
Disease control CompletedThis study tested a combination of two drugs, sorafenib and bevacizumab, in 83 people with advanced colorectal cancer that had spread and stopped responding to standard treatments. The goal was to see if the combination could slow or stop tumor growth. Participants received both …
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 07:57 UTC
-
New chemo combo shows promise for young leukemia patients
Disease control CompletedThis study tested a combination of chemotherapy drugs in 318 adolescents and young adults (ages not specified) with newly diagnosed acute lymphoblastic leukemia (ALL). The goal was to see how well the treatment worked at killing cancer cells and stopping the disease from coming b…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
Can an arthritis drug boost colon cancer treatment?
Disease control CompletedThis study looked at whether adding the drug celecoxib (often used for arthritis) to standard chemotherapy helps prevent colon cancer from coming back after surgery. About 2,500 patients with stage III colon cancer took part. They received either 6 or 12 rounds of chemo, plus eit…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New hope for mantle cell lymphoma: targeted drug after transplant shows promise
Disease control CompletedThis study tested whether giving the drug bortezomib after intensive chemotherapy, immunotherapy, and a stem cell transplant could help keep mantle cell lymphoma from coming back. 151 patients took part. The goal was to see if this approach improved how long people lived without …
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Less invasive lung surgery may be just as effective for small tumors
Disease control CompletedThis study compared two types of surgery for people with small (≤2 cm) early-stage lung cancer: removing the entire lobe (lobectomy) versus removing only the tumor and a small margin (sublobar resection). The goal was to see if the less invasive approach works just as well with f…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Simple therapy may stop arm swelling in breast cancer survivors
Prevention CompletedThis study looked at whether adding physical therapy to education helps prevent lymphedema (arm swelling) in women treated for breast cancer. Women with stage I to III breast cancer who had lymph nodes removed from their armpit took part. The goal was to see if a personalized phy…
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated May 26, 2026 07:25 UTC
-
MRI before breast surgery: helpful or just extra cost?
Knowledge-focused CompletedThis study looked at whether having a breast MRI before surgery helps women with early-stage breast cancer get better surgical results. About 317 women with certain types of breast cancer took part. The goal was to see if the MRI could reduce the need for repeat surgeries and imp…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC